|
|
|
|
International Clinical Trials |
| |
| International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of
key topics pertinent to the clinical trials sector.
Published quarterly, the journal offers a platform of
communication and information-sharing for executive and strategic decision makers, seeking
out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.
Prompted by the synergies between trial operations and wider contract research and outsourcing
issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015,
in a move that brings added value to both brands. With EPC now an inserted edition within ICT,
industry practitioners across these complementary subject areas now
have unrivalled access
to a wealth of shared views and analyses.
Connect with us on Twitter: follow @IntClinTrials
|
|
|
|
|
|
 |
News and Press Releases |
 |
Drug delivery innovation across Europe improves for third consecutive year ahead of Pharmapack Europe
Paris, 25th June 2021: Ahead of Pharmapack Europe 2021 (Paris
Expo, Porte de Versailles, 13-14 October) – the returning European
event dedicated to drug packaging and delivery – there has been a huge
swathe of innovation across the industry, with more than 53 FDA
approvals in 2020 and 26 approvals in 2021.
More info >> |
|
 |
White Papers |
 |
|
What is process characterization?
EXPUTEC
Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >> |
|
|
